LGE-15273-13208
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 633 / MO
- Registered
- 2020-12-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-26
Registered in v-safe
-
2020-12-26
Dose 1 — Pfizer-BioNTech
- 2020-12-26
- 2020-12-27
-
2020-12-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · None · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-28
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-09
-
2021-01-16
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-30
- 2021-02-06
- 2021-02-20
- 2021-03-01
- 2021-04-18
- 2021-07-17
-
2022-01-19
Survey response — 12 months, dose 2MedDRA: Balance disorder, Brain fog, Chest discomfort, Chills, Cough, Diarrhoea, Fatigue, Headache, Heart rate increased, Myalgia, Night sweats, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Sore throat, cough, night sweats, chills, diarrhea, muscle aches, headache, exhaustion, chest heaviness, elevated, heartbeat, loss of balance, foggyheadedMedDRA releases: 2024-11 · check-in free text available
-
2022-01-19
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Pfizer-BioNTech | |
| 2 | 2021-01-16 | Pfizer-BioNTech |
Call center
3 call center cases
1 unsuccessful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 10 — 12 months, dose 2
Symptoms: Sore throat, cough, night sweats, chills, diarrhea, muscle aches, headache, exhaustion, chest heaviness, elevated, heartbeat, loss of balance, foggyheaded
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Balance disorder | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Night sweats | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release